These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 9142201

  • 1. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H, Stuve W, Behrendt H.
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [Abstract] [Full Text] [Related]

  • 2. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
    Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, Zee B.
    J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL, Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT.
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [Abstract] [Full Text] [Related]

  • 5. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
    Oberlin O, Leverger G, Pacquement H, Raquin MA, Chompret A, Habrand JL, Terrier-Lacombe MJ, Bey P, Bertrand Y, Rubie H.
    J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434
    [Abstract] [Full Text] [Related]

  • 6. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R, Carde P, Henry-Amar M, Tarayre M, Thomas J, Hagenbeek A, Monconduit M, de Pauw BE, Breed WP, Verdonck L.
    J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
    [Abstract] [Full Text] [Related]

  • 7. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
    van den Berg H, Furstner F, van den Bos C, Behrendt H.
    Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
    [Abstract] [Full Text] [Related]

  • 8. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ, Fryer CJ, Davis PC, Nachman J, Krailo MD, O'Brien RT, Collins RD, Whalen T, Reardon D, Trigg ME, Gilchrist GS.
    J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
    [Abstract] [Full Text] [Related]

  • 9. Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
    Salvagno L, Sorarù M, Sotti G, Aversa S, Chiarion Sileni V, Mazzarotto R, Scarzello G, Bianco A, Pappagallo GL, Fiorentino MV.
    Ann Oncol; 1995 Feb; 6(2):173-9. PubMed ID: 7540419
    [Abstract] [Full Text] [Related]

  • 10. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD, Chauvenet AR.
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G, Santoro A, Bonfante V, Valagussa P.
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [Abstract] [Full Text] [Related]

  • 16. Treatment of childhood Hodgkin's disease without radiotherapy.
    van den Berg H, Zsiros J, Behrendt H.
    Ann Oncol; 1997 Apr; 8 Suppl 1():15-7. PubMed ID: 9187423
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
    Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA.
    N Engl J Med; 1992 Nov 19; 327(21):1478-84. PubMed ID: 1383821
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.